The DOI matches its Crossref record; 62 of the 62 references it cites were found in a registry or an index.
Nuclear accumulation of p53 protein is mediated by several nuclear localization signals and plays a role in tumorigenesis.
Open accessAbstract
The basic carboxy terminus of p53 plays an important role in directing the protein into the nuclear compartment. The C terminus of the p53 molecule contains a cluster of several nuclear localization signals (NLSs) that mediate the migration of the protein into the cell nucleus. NLSI, the most active domain, is highly conserved in genetically diverged species and shares perfect homology with consensus NLS sequences found in other nuclear proteins. The other two NLSs, II and III, appear to be less effective and less conserved. Although nuclear localization is dictated primarily by the NLSs inherent in the primary amino acid sequence, the actual nuclear homing can be modified by interactions with other proteins expressed in the cell. Comparison between wild-type p53 and naturally occurring mutant p53 showed that both protein categories could migrate into the nucleus of rat primary embryonic fibroblasts by essentially similar mechanisms. Nuclear localization of both proteins was totally dependent on the existence of functional NLS domains. In COS cells, however, we found that NLS-deprived wild-type p53 molecules could migrate into the nucleus by complexing with another nuclear protein, simian virus 40 large-T antigen. Wild-type and mutant p53 proteins differentially complexed with viral or cellular proteins, which may significantly affect the ultimate compartmentalization of p53 in the cell; this finding suggests that the actual subcellular compartmentalization of proteins may differ in various cell type milieux and may largely be affected by the ability of these proteins to complex with other proteins expressed in the cell. Experiments designed to test the physiological significance of p53 subcellular localization indicated that nuclear localization of mutant p53 is essential for this protein to enhance the process of malignant transformation of partially transformed cells, suggesting that p53 functions within the cell nucleus.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The text we found for this paper looks like another document, so the self-check wasn’t run.
Citations
Cites
Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4
LAEMMLI, U. K. (1970) · Nature · doi:10.1038/227680a0 · Cited by 249,961
A new technique for the assay of infectivity of human adenovirus 5 DNA
Graham, F. L., & van der Eb, A. J. (1973) · Virology · doi:10.1016/0042-6822(73)90341-3 · Cited by 9,451
Kessler, S. W. (1975) · The Journal of Immunology · doi:10.4049/jimmunol.115.6.1617 · Cited by 2,915
Mutations in the p53 gene occur in diverse human tumour types
Nigro, J. M., Baker, S. J., Preisinger, A. C., Jessup, J. M., Hosteller, R., Cleary, K., Signer, S. H., Davidson, N., Baylin, S., Devilee, P., et al. (1989) · Nature · doi:10.1038/342705a0 · Cited by 2,733
A short amino acid sequence able to specify nuclear location
Kalderon, D., Roberts, B. L., Richardson, W. D., & Smith, A. E. (1984) · Cell · doi:10.1016/0092-8674(84)90457-4 · Cited by 2,507
T antigen is bound to a host protein in SY40-transformed cells
LANE, D. P., & CRAWFORD, L. V. (1979) · Nature · doi:10.1038/278261a0 · Cited by 2,394
Chromosome 17 Deletions and p53 Gene Mutations in Colorectal Carcinomas
Baker, S. J., Fearon, E. R., Nigro, J. M., Hamilton, S. R., Preisinger, A. C., Jessup, J. M., vanTuinen, P., Ledbetter, D. H., Barker, D. F., Nakamura, Y., et al. (1989) · Science · doi:10.1126/science.2649981 · Cited by 2,066
The p53 proto-oncogene can act as a suppressor of transformation
Finlay, C. A., Hinds, P. W., & Levine, A. J. (1989) · Cell · doi:10.1016/0092-8674(89)90045-7 · Cited by 1,987
Linzer, D. I. H., & Levine, A. J. (1979) · Cell · doi:10.1016/0092-8674(79)90293-9 · Cited by 1,813
Sequence requirements for nuclear location of simian virus 40 large-T antigen
Kalderon, D., Richardson, W. D., Markham, A. F., & Smith, A. E. (1984) · Nature · doi:10.1038/311033a0 · Cited by 1,286
Cited by
A role for sunlight in skin-cancer – UV-induced p53 mutations in squamous-cell carcinoma
Brash, D. E., Rudolph, J. A., Simon, J. A., Lin, A., McKenna, G. J., Baden, H. P., Halperin, A. J., & Pontén, J. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.22.10124 · Cited by 1,959
Vogelstein, B. (1992) · Cell · doi:10.1016/0092-8674(92)90421-8 · Cited by 1,862
When mutants gain new powers: News from the mutant p53 field
Brosh, R., & Rotter, V. (2009) · Nature Reviews Cancer · doi:10.1038/nrc2693 · Cited by 1,132
Self-citationStommel, J. M., Marchenko, N. D., Jimenez, G. S., Moll, U. M., Hope, T. J., & Wahl, G. M. (1999) · The EMBO Journal · doi:10.1093/emboj/18.6.1660 · Cited by 738
Mapping of the p53 and mdm-2 interaction domains.
Chen, J., Marechal, V, & Levine, A. J. (1993) · Molecular and Cellular Biology · doi:10.1128/mcb.13.7.4107 · Cited by 689
Stabilization of the p53 tumor suppressor is induced by adenovirus 5 E1A and accompanies apoptosis.
Lowe, S. W., & Ruley, H. E. (1993) · Genes & Development · doi:10.1101/gad.7.4.535 · Cited by 666
Oncogenic mutations of the p53 tumor suppressor: the demons of the guardian of the genome.
Sigal, A., & Rotter, V. (2000) · PubMed · Cited by 869
Self-citationTwenty years of p53 research: structural and functional aspects of the p53 protein
May, P., & May, E. (1999) · Oncogene · doi:10.1038/sj.onc.1203285 · Cited by 663
Two distinct mechanisms alter p53 in breast cancer: mutation and nuclear exclusion.
Moll, U. M., Riou, G., & Levine, A. J. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.15.7262 · Cited by 575
Induction of apoptosis in HeLa cells by trans-activation-deficient p53.
Haupt, Y., Rowan, S., Shaulian, E., Vousden, K. H., & Oren, M. (1995) · Genes & Development · doi:10.1101/gad.9.17.2170 · Cited by 545
p53 in growth control and neoplasia
Gottlieb, T. M., & Oren, M. (1996) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/0304-419x(95)00019-c · Cited by 481
Nuclear transport and cancer: from mechanism to intervention
Kau, T. R., Way, J. C., & Silver, P. A. (2004) · Nature Reviews Cancer · doi:10.1038/nrc1274 · Cited by 468
A comparison of the biological activities of wild‐type and mutant p53
Zambetti, G. P., & Levine, A. J. (1993) · The FASEB Journal · doi:10.1096/fasebj.7.10.8344485 · Cited by 413
Multiple C-Terminal Lysine Residues Target p53 for Ubiquitin-Proteasome-Mediated Degradation
Rodriguez, M. S., Desterro, J. M. P., Lain, S., Lane, D. P., & Hay, R. T. (2000) · Molecular and Cellular Biology · doi:10.1128/mcb.20.22.8458-8467.2000 · Cited by 389
Stress Signals Utilize Multiple Pathways To Stabilize p53
Ashcroft, M., Taya, Y., & Vousden, K. H. (2000) · Molecular and Cellular Biology · doi:10.1128/mcb.20.9.3224-3233.2000 · Cited by 356
Nikolaev, A. Y., Li, M., Puskas, N., Qin, J., & Gu, W. (2003) · Cell · doi:10.1016/s0092-8674(02)01255-2 · Cited by 356
Shaulian, E., Zauberman, A., Ginsberg, D., & Oren, M. (1992) · Molecular and Cellular Biology · doi:10.1128/mcb.12.12.5581 · Cited by 342
Donehower, L. A., & Bradley, A. (1993) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/0304-419x(93)90004-v · Cited by 333
Kau, T. R., Schroeder, F., Ramaswamy, S., Wojciechowski, C. L., Zhao, J. J., Roberts, T. M., Clardy, J., Sellers, W. R., & Silver, P. A. (2003) · Cancer Cell · doi:10.1016/s1535-6108(03)00303-9 · Cited by 329
Cytoplasmic Sequestration of Wild-Type p53 Protein Impairs the G 1 Checkpoint after DNA Damage
Moll, U. M., Ostermeyer, A. G., Haladay, R., Winkfield, B., Frazier, M., & Zambetti, G. (1996) · Molecular and Cellular Biology · doi:10.1128/mcb.16.3.1126 · Cited by 277
Frequent p53 mutations in head and neck cancer.
Somers, K. D., Merrick, M. A., Lopez, M. E., Incognito, L. S., Schechter, G. L., & Casey, G. (1992) · PubMed · Cited by 276
Cytoplasmic destruction of p53 by the endoplasmic reticulum‐resident ubiquitin ligase ‘Synoviolin’
Yamasaki, S., Yagishita, N., Sasaki, T., Nakazawa, M., Kato, Y., Yamadera, T., Bae, E., Toriyama, S., Ikeda, R., Zhang, L., et al. (2007) · The EMBO Journal · doi:10.1038/sj.emboj.7601490 · Cited by 275
The p53 protein is an unusually shaped tetramer that binds directly to DNA.
Friedman, P. N., Chen, X., Bargonetti, J., & Prives, C. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.8.3319 · Cited by 264
Polo-like Kinase 1 (Plk1) Inhibits p53 Function by Physical Interaction and Phosphorylation
Ando, K., Ozaki, T., Yamamoto, H., Furuya, K., Hosoda, M., Hayashi, S., Fukuzawa, M., & Nakagawara, A. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m314182200 · Cited by 264
Jaros, E., Perry, R., Adam, L., Kelly, P., Crawford, P., Kalbag, R., Mendelow, A., Sengupta, R., & Pearson, A. (1992) · British Journal of Cancer · doi:10.1038/bjc.1992.273 · Cited by 264
Characterization of a Novel Tripartite Nuclear Localization Sequence in the EGFR Family
Hsu, S.-C., & Hung, M.-C. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m610014200 · Cited by 260
p53 Protein Exhibits 3′-to-5′ Exonuclease Activity
Mummenbrauer, T., Janus, F., Müller, B., Wiesmüller, L., Deppert, W., & Grosse, F. (1996) · Cell · doi:10.1016/s0092-8674(00)81309-4 · Cited by 249
p53 domains: identification and characterization of two autonomous DNA-binding regions.
Wang, Y., Reed, M., Wang, P., Stenger, J. E., Mayr, G., Anderson, M. E., Schwedes, J. F., & Tegtmeyer, P. (1993) · Genes & Development · doi:10.1101/gad.7.12b.2575 · Cited by 239
Regulation of tumor suppressors by nuclear-cytoplasmic shuttling
Fabbro, M., & Henderson, B. R. (2003) · Experimental Cell Research · doi:10.1016/s0014-4827(02)00019-8 · Cited by 231
C-terminal modifications regulate MDM2 dissociation and nuclear export of p53
Carter, S., Bischof, O., Dejean, A., & Vousden, K. H. (2007) · Nature Cell Biology · doi:10.1038/ncb1562 · Cited by 225
Discrimination between NL1- and NL2-Mediated Nuclear Localization of the Glucocorticoid Receptor
Savory, J. G. A., Hsu, B., Laquian, I. R., Giffin, W., Reich, T., Haché, R. J. G., & Lefebvre, Y. A. (1999) · Molecular and Cellular Biology · doi:10.1128/mcb.19.2.1025 · Cited by 222
“However, some transcription factors, including the glucocorticoid hormone receptor (GR), contain additional NLSs that occur in other regions of the proteins (69, 89, 95, 99).”
BackgroundRegulation of Human p53 Activity and Cell Localization by Alternative Splicing
Ghosh, A., Stewart, D., & Matlashewski, G. (2004) · Molecular and Cellular Biology · doi:10.1128/mcb.24.18.7987-7997.2004 · Cited by 221
Regulation of p53 localization
Liang, S., & Clarke, M. F. (2001) · European Journal of Biochemistry · doi:10.1046/j.1432-1327.2001.02227.x · Cited by 218
Structural Aspects of the p53 Protein in Relation to Gene Evolution: A Second Look
Soussi, T., & May, P. (1996) · Journal of Molecular Biology · doi:10.1006/jmbi.1996.0425 · Cited by 208
Li, X., & Coffino, P. (1996) · Journal of Virology · doi:10.1128/jvi.70.7.4509-4516.1996 · Cited by 201
Eizenberg, O., Faber-Elman, A., Gottlieb, E., Oren, M., Rotter, V., & Schwartz, M. (1996) · Molecular and Cellular Biology · doi:10.1128/mcb.16.9.5178 · Cited by 199
Self-citationFrazier, M. W., He, X., Wang, J., Gu, Z., Cleveland, J. L., & Zambetti, G. P. (1998) · Molecular and Cellular Biology · doi:10.1128/mcb.18.7.3735 · Cited by 194
Quaternary structures of tumor suppressor p53 and a specific p53 DNA complex
Tidow, H., Melero, R., Mylonas, E., Freund, S. M. V., Grossmann, J. G., Carazo, J. M., Svergun, D. I., Valle, M., & Fersht, A. R. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0705069104 · Cited by 170
Prokocimer, M., & Rotter, V (1994) · Blood · doi:10.1182/blood.v84.8.2391.2391 · Cited by 184
Self-citationThe regulation of protein transport to the nucleus by phosphorylation
Jans, D. A. (1995) · Biochemical Journal · doi:10.1042/bj3110705 · Cited by 182
Jimenez, G. S., Khan, S. H., Stommel, J. M., & Wahl, G. M. (1999) · Oncogene · doi:10.1038/sj.onc.1203013 · Cited by 177
Cannon, J. V., & Lane, D. P. (1991) · Nature · doi:10.1038/349802a0 · Cited by 173
Proteins of the S100 family regulate the oligomerization of p53 tumor suppressor
Fernandez-Fernandez, M. R., Veprintsev, D. B., & Fersht, A. R. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0501459102 · Cited by 171
The p53 tumor suppressor protein, a modulator of cell proliferation.
Ullrich, S. J., Anderson, C. W., Mercer, W. E., & Appella, E. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)49524-0 · Cited by 168
AirID, a novel proximity biotinylation enzyme, for analysis of protein–protein interactions
Kido, K., Yamanaka, S., Nakano, S., Motani, K., Shinohara, S., Nozawa, A., Kosako, H., Ito, S., & Sawasaki, T. (2020) · eLife · doi:10.7554/elife.54983 · Cited by 163
Mutational inactivation of the p53 gene in the human erythroid leukemic K562 cell line
Law, J. C., Ritke, M. K., Yalowich, J. C., Leder, G. H., & Ferrell, R. E. (1993) · Leukemia Research · doi:10.1016/0145-2126(93)90161-d · Cited by 162
Involvement of p53 in cell differentiation and development
Almog, N., & Rotter, V. (1997) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/s0304-419x(97)00012-7 · Cited by 162
Self-citationInvolvement of wild-type p53 in pre-B-cell differentiation in vitro.
Shaulsky, G., Goldfinger, N., Peled, A., & Rotter, V (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.20.8982 · Cited by 160
Self-citationSims, A. C., Tilton, S. C., Menachery, V. D., Gralinski, L. E., Schäfer, A., Matzke, M. M., Webb-Robertson, B.-J. M., Chang, J., Luna, M. L., Long, C. E., et al. (2013) · Journal of Virology · doi:10.1128/jvi.02520-12 · Cited by 158
DNA damage induced p53 stabilization: no indication for an involvement of p53 phosphorylation
Blattner, C., Tobiasch, E., Litfen, M., Rahmsdorf, H. J., & Herrlich, P. (1999) · Oncogene · doi:10.1038/sj.onc.1202480 · Cited by 151
Greenway, A. L., McPhee, D. A., Allen, K., Johnstone, R. W., Holloway, G., MILLS, J. S., Azad, A. A., Sankovich, S., & Lambert, P. F. (2002) · Journal of Virology · doi:10.1128/jvi.76.6.2692-2702.2002 · Cited by 157
Tanaka, N., Kaneko, K., Asao, H., Kasai, H., Endo, Y., Fujita, T., Takeshita, T., & Sugamura, K. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.27.19129 · Cited by 146
Liang, S.-H., & Clarke, M. F. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.46.32699 · Cited by 108
Structural Biology of the Tumor Suppressor p53 and Cancer‐Associated Mutants
(2007) · Advances in Cancer Research · doi:10.1016/s0065-230x(06)97001-8 · Cited by 106
MDM2-dependent ubiquitination of nuclear and cytoplasmic P53
Yu, Z. K., Geyer, R. K., & Maki, C. G. (2000) · Oncogene · doi:10.1038/sj.onc.1203980 · Cited by 151
Cocompartmentalization of p53 and Mdm2 Is a Major Determinant for Mdm2-Mediated Degradation of p53
Xirodimas, D. P., Stephen, C. W., & Lane, D. P. (2001) · Experimental Cell Research · doi:10.1006/excr.2001.5314 · Cited by 150
Functional analysis and intracellular localization of p53 modified by SUMO-1
Kwek, S. S., Derry, J. J., Tyner, A. L., Shen, Z., & Gudkov, A. V. (2001) · Oncogene · doi:10.1038/sj.onc.1204362 · Cited by 149
Oligomerization Is Required for p53 to be Efficiently Ubiquitinated by MDM2
Maki, C. G. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.23.16531 · Cited by 130
Mechanisms and Signals for the Nuclear Import of Proteins
Freitas, N., & Cunha, C. V. (2009) · Current Genomics · doi:10.2174/138920209789503941 · Cited by 148
The effects of antibodies to heat shock protein 70 in fertilization and embryo development
Matwee, C., Kamaruddin, M., Betts, D. H., Basrur, P. K., & King, W. A. (2001) · Molecular Human Reproduction · doi:10.1093/molehr/7.9.829 · Cited by 124
Stress-mediated nuclear stabilization of p53 is regulated by ubiquitination and importin-α3 binding
Marchenko, N. D., Hanel, W., Li, D., Becker, K., Reich, N., & Moll, U. M. (2010) · Cell Death & Differentiation · doi:10.1038/cdd.2009.173 · Cited by 123
“weaker motifs with single stretches of basic amino acids.(15,16) Basic NLS sequences are commonly recognized by an adapter family of importin-a proteins.”
p53-A natural cancer killer: Structural insights and therapeutic concepts
Römer, L., Klein, C., Dehner, A., Kessler, H., & Buchner, J. (2006) · Angewandte Chemie International Edition · doi:10.1002/anie.200600611 · Cited by 93
Xia, Y. P., Yeh, C., Ou, J.-H. J., & Lai, M. M. C. (1992) · Journal of Virology · doi:10.1128/jvi.66.2.914-921.1992 · Cited by 118
Activation of p53 by roscovitine-mediated suppression of MDM2 expression
Lu, W., Chen, L., Peng, Y., & Chen, J. (2001) · Oncogene · doi:10.1038/sj.onc.1204412 · Cited by 131
Fischbach, A., Krüger, A., Hampp, S., Assmann, G. M., Rank, L., Hufnagel, M., Stöckl, M. T., Fischer, J. M. F., Veith, S., Rossatti, P., et al. (2017) · Nucleic Acids Research · doi:10.1093/nar/gkx1205 · Cited by 122
Yang, Z., Gu, L., Roméo, P., Bories, D., Motohashi, H., Yamamoto, M. P., & Engel, J. D. (1994) · Molecular and Cellular Biology · doi:10.1128/mcb.14.3.2201 · Cited by 114
A DNA binding domain is contained in the C-terminus ofwild typep53 protein
Foord, O., Bhattacharya, P., Reich, Z., & Rotter, V. (1991) · Nucleic Acids Research · doi:10.1093/nar/19.19.5191 · Cited by 113
Self-citationThe transforming activity of simian virus 40 large tumor antigen
Manfredi, J. J., & Prives, C. L. (1994) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/0304-419x(94)90006-x · Cited by 129
Wang, X., Zalcenstein, A., & Oren, M. (2003) · Cell Death and Differentiation · doi:10.1038/sj.cdd.4401181 · Cited by 112
Veeranki, S., & Choubey, D. (2011) · Molecular Immunology · doi:10.1016/j.molimm.2011.11.004 · Cited by 121
Elledge, R. M., & Lee, W. (1995) · BioEssays · doi:10.1002/bies.950171105 · Cited by 107
Regulation of p53 tetramerization and nuclear export by ARC
Foo, R., Nam, Y., Ostreicher, M. J., Metzl, M. D., Whelan, R. S., Peng, C.-F., Ashton, A. W., Fu, W., Mani, K. M., Chin, S., et al. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0710017104 · Cited by 112
Slingerland, J., Jenkins, J. R., & Benchimol, S. (1993) · The EMBO Journal · doi:10.1002/j.1460-2075.1993.tb05744.x · Cited by 104
Jans, D. A., Moll, T., Nasmyth, K., & Jans, P. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.29.17064 · Cited by 103
Mutation of Phosphoserine 389 Affects p53 Function in Vivo
Hao, M., Lowy, A. M., Kapoor, M., Deffie, A. M., Liu, G., & Lozano, G. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.46.29380 · Cited by 102
Bayle, J. H., Elenbaas, B., & Levine, A. J. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.12.5729 · Cited by 119
p53 Is Covalently Linked to 5.8S rRNA
Fontoura, B. M. A., Sorokina, E. A., David, E., & Carroll, R. B. (1992) · Molecular and Cellular Biology · doi:10.1128/mcb.12.11.5145 · Cited by 101
Caleffi, M. M., Teague, M. W., Jensen, R. A., Vnencak‐Jones, C. L., Dupont, W. D., & Parl, F. F. (1994) · Cancer · doi:10.1002/1097-0142(19940415)73:8<2147::aid-cncr2820730820>3.0.co;2-5 · Cited by 100
Ubc13: the Lys63 ubiquitin chain building machine
Hodge, C. D., Spyracopoulos, L., & Glover, J. N. M. (2016) · Oncotarget · doi:10.18632/oncotarget.10948 · Cited by 107
Zacksenhaus, E., Bremner, R., Phillips, R. A., & Gallie, B. L. (1993) · Molecular and Cellular Biology · doi:10.1128/mcb.13.8.4588 · Cited by 97
Dissociation of the recombination control and the sequence-specific transactivation function of P53
Dudenhöffer, C., Kurth, M., Janus, F., Deppert, W., & Wiesmüller, L. (1999) · Oncogene · doi:10.1038/sj.onc.1202964 · Cited by 90
Tumor Suppressor p53 Mutations and Breast Cancer: A Critical Analysis
Ozbun, M. A., & Butel, J. S. (1995) · Advances in cancer research · doi:10.1016/s0065-230x(08)60252-3 · Cited by 103
Nuclear transport of galectin-3 and its therapeutic implications
Funasaka, T., Raz, A., & Nangia‐Makker, P. (2014) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2014.03.004 · Cited by 91
Binding to Intracellular Targets of the Metastasis-Inducing Protein, S100A4 (p9Ka)
Chen, H., Fernig, D. G., Rudland, P. S., Sparks, A., Wilkinson, M. C., & Barraclough, R. (2001) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2001.5517 · Cited by 87
Direct involvement of p53 in programmed cell death of oligodendrocytes.
Eizenberg, O., Faber‐Elman, A., Gottlieb, E., Oren, M., Rotter, V., & Schwartz, M. (1995) · The EMBO Journal · doi:10.1002/j.1460-2075.1995.tb07097.x · Cited by 87
Self-citationUberti, D. L., Yavin, E., Gil, S., Kameshwar‐Rao, A. S. V. R., Goldfinger, N., & Rotter, V. (1999) · Molecular Brain Research · doi:10.1016/s0169-328x(98)00339-8 · Cited by 95
Self-citationBerghe, L. V. D., Laurell, H., Huez, I., Zanibellato, C., Prats, H., & Bugler, B. (2000) · Molecular Endocrinology · doi:10.1210/me.14.11.1709 · Cited by 81
Yang, C., Patten, C. W.-V., Planchon, S. M., Wuerzberger‐Davis, S. M., Davis, T. W., Cuthill, S., Miyamoto, S., & Boothman, D. A. (2000) · The FASEB Journal · doi:10.1096/fasebj.14.2.379 · Cited by 80
Signals mediating nuclear targeting and their regulation: Application in drug delivery
Jans, D. A., Chan, C. K., & Huebner, S. (1998) · Medicinal Research Reviews · doi:10.1002/(sici)1098-1128(199807)18:4<189::aid-med1>3.0.co;2-r · Cited by 80
Novel small molecules potentiate premature termination codon readthrough by aminoglycosides
Baradaran‐Heravi, A., Balgi, A. D., Zimmerman, C., Choi, K., Shidmoossavee, F. S., Tan, J. S. C., bergeaud, C., Krause, A., Flibotte, S., Shimizu, Y., et al. (2016) · Nucleic Acids Research · doi:10.1093/nar/gkw638 · Cited by 84
Top, B., Mooi, W. J., Klaver, S. G., Boerrigter, L., Wisman, P., Elbers, H. R. J., Visser, S., & Rodenhuis, S. (1995) · International Journal of Cancer · doi:10.1002/ijc.2910640203 · Cited by 79
Ozaki, T., Naka, M., Takada, N., Tada, M., Sakiyama, S., & Nakagawara, A. (1999) · PubMed · Cited by 78
Gotoh, T., Vila-Caballer, M., Liu, J., Schiffhauer, S., & Finkielstein, C. V. (2014) · Molecular Biology of the Cell · doi:10.1091/mbc.e14-05-0994 · Cited by 79
Nuclear Exclusion of Wild-Type p53 in Immortalized Human Retinoblastoma Cells
Schlamp, C. L., Poulsen, G. L., Nork, T. M., & Nickells, R. W. (1997) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/89.20.1530 · Cited by 75
Laín, S., Xirodimas, D. P., & Lane, D. P. (1999) · Experimental Cell Research · doi:10.1006/excr.1999.4672 · Cited by 80
Impaired p53 Expression, Function, and Nuclear Localization in Calreticulin-deficient Cells
Mesaeli, N., & Phillipson, C. S. (2004) · Molecular Biology of the Cell · doi:10.1091/mbc.e03-04-0251 · Cited by 82
Casso, D. J., & Beach, D. (1996) · Molecular and General Genetics MGG · doi:10.1007/s004380050259 · Cited by 78
Schaap, P. J., Riet, J. V. '., Woldringh, C. L., & Raué, H. A. (1991) · Journal of Molecular Biology · doi:10.1016/0022-2836(91)80216-h · Cited by 71
Identification of the Nuclear Localization Signal of the POU Domain Protein Tst-1/Oct6
Sock, E., Enderich, J., Rosenfeld, M. G., & Wegner, M. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.29.17512 · Cited by 71
Mutant p53 expression in prostate carcinoma
Veldhuizen, P. J. V., Sadasivan, R., Garcia, F. U., Austenfeld, M. S., & Stephens, R. L. (1993) · The Prostate · doi:10.1002/pros.2990220104 · Cited by 71
Metadata
- Authors
- Shaulsky, G., Goldfinger, N., Ben-Ze'ev, A., & Rotter, V
- Affiliations
- Weizmann Institute of Science (IL)
- ORCID
- Shaulsky, G
- Venue
- Molecular and Cellular Biology
- Publisher
- Informa UK Limited
- Published
- 1990-12
- Volume
- 10
- Issue
- 12
- Pages
- 6565-6577
- ISSN
- 0270-7306 (ISSN-L)
- 1098-5549
- PMC
- PMC362933
- OpenAlex
- W1806610286
- Cited by
- 356
- References
- 60
- Citations by year
- 2026: 3 · 2025: 3 · 2024: 1 · 2023: 4 · 2022: 4 · 2021: 6 · 2020: 7 · 2019: 2 · 2018: 5 · 2017: 6 · 2016: 4 · 2015: 5 · 2014: 10 · 2013: 11 · 2012: 5
- FWCI
- 11.81
- Type
- journal article
- Language
- en
- Open access
- green
- pmc.ncbi.nlm.nih.gov
- Locations
- Molecular and Cellular Biology (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (publishedVersion)
- Funders
- Princeton University
- Topics
- Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Nuclear Structure and Function
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Structure and Dynamics
- Keywords
- p53, nuclear localization signal, nuclear accumulation, p53 C-terminal domain, SV40 large T antigen, protein-protein interaction, subcellular localization, carcinogenesis, malignant transformation, mutant p53, embryonic fibroblasts
- MeSH terms
- Amino Acid Sequence, Animals, Base Sequence, Cell Line, Cell Nucleus, Cell Transformation, Neoplastic, Chromosome Deletion, Cloning, Molecular, Humans, Molecular Sequence Data, Plasmids, Sequence Homology, Nucleic Acid, Transfection, Signal Transduction, Tumor Suppressor Protein p53, Mutagenesis, Site-Directed, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
A second model labelled each claim on 2026-11-15 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.